Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Pelayaran Nasional Ekalya Purnamasari Tbk. (ELPI) vs Tempo Scan Pacific Tbk. (TSPC)

Pelayaran Nasional Ekalya Purnamasari Tbk.Trading
Tempo Scan Pacific Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Pelayaran Nasional Ekalya Purnamasari Tbk. dan Tempo Scan Pacific Tbk.: Pelayaran Nasional Ekalya Purnamasari Tbk. diperdagangkan di Rp990 (kapitalisasi pasar 7,54 T, volume 24 jam 1,19 jt), sedangkan Tempo Scan Pacific Tbk. diperdagangkan di Rp2.520 (kapitalisasi pasar 11,18 T, volume 24 jam 613 rb). Perbedaan utamanya: Tempo Scan Pacific Tbk. lebih besar dari sisi kapitalisasi pasar, dan Pelayaran Nasional Ekalya Purnamasari Tbk. lebih aktif diperdagangkan (1,19 jt vs 613 rb). Mana yang lebih baik tergantung tujuan investasimu.

ELPITSPC
Kapitalisasi Pasar
7,54 T11,18 T
Volume
1,19 jt613 rb
Lot
11,86 rb6,13 rb
Perputaran
1,18 M1,54 M
Harga Rata-rata
993,62.511,52
Nilai Transaksi
1,18 M1,54 M
Harga Ekuilibrium Indikatif
9902.520
Volume Ekuilibrium Indikatif
33517

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

ELPI
Lihat detail
TSPC
Lihat detail

Tentang Pelayaran Nasional Ekalya Purnamasari Tbk.

PT Pelayaran Nasional Ekalya Purnamasari Tbk (the Entity) was established based on Notarial Deed No. 11 of Grace Margareth Goenawan, S.H., dated April 20, 1992 in Ambon. PT Pelayaran Nasional Ekalya Purnamasari is the parent Entity, whereas PT Kreasi Cipta Timur is the ultimate parent of the Entity. The Entity’s Ultimate Beneficiary Ownership (UBO) is Eka Taniputra.

Selengkapnya di halaman ELPI

Tentang Tempo Scan Pacific Tbk.

PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.

Selengkapnya di halaman TSPC